INVESTIGATING MALONDIALDEHYDE AND HOMOCYSTEINE LEVELS IN WOMEN WITH UNEXPLAINED INFERTILITY: A HOSPITAL-BASED RETROSPECTIVE STUDY

Abstract

Malondialdehyde (MDA) and homocysteine (plasma(t)Hcy) levels in females who have experienced unexplained infertility are the focus of this investigation. This present study was a hospital-based, case-control study, where we took fifty unexplained-infertility females and fifty normal healthy as controls. MDA and hcy levels were estimated utilizing blood tests taken from the case and control groups. The present study found higher levels of MDA and hcy in the case than in the controls. These results observed the correlation between MDA and hcy levels and female infertility without an apparent cause. These findings could have important implications for future research and the development of infertility treatments. In conclusion, measuring MDA and plasma(t)hcy levels may be essential in determining the cause of unexplained female infertility. This study suggests that these substances may be associated with this condition, and their levels could be used to identify and treat infertility in women. Further, more study is needed to determine the meticulous nature of the relationship between MDA, homocysteine, and unexplained infertility. Still, these findings could be a valuable starting point for future investigations.